Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities Conference
Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company focused on commercializing dermatologic products, has announced its participation in the 3rd Annual ROTH Healthcare Opportunities Conference. The event will take place at the Metropolitan Club in New York, NY.
Key details of Biofrontera's presentation include:
- Date: October 9, 2024
- Time: 12:30 - 1:10 PM ET
- Format: Live Presentation
The company has also made provisions for one-on-one meetings during the conference. Interested parties are advised to contact their Roth representative to schedule these meetings.
This presentation offers an opportunity for Biofrontera to showcase its developments in the dermatologic products sector to potential investors and industry professionals.
Biofrontera Inc. (NASDAQ:BFRI), un'azienda biofarmaceutica focalizzata sulla commercializzazione di prodotti dermatologici, ha annunciato la sua partecipazione alla 3ª Conferenza Annuale ROTH sulle Opportunità Sanitarie. L'evento si svolgerà al Metropolitan Club di New York, NY.
Dettagli chiave della presentazione di Biofrontera includono:
- Data: 9 ottobre 2024
- Orario: 12:30 - 13:10 ET
- Formato: Presentazione dal vivo
L'azienda ha anche previsto incontri one-to-one durante la conferenza. Le parti interessate sono invitate a contattare il proprio rappresentante Roth per programmare questi incontri.
Questa presentazione offre a Biofrontera l'opportunità di mostrare i propri sviluppi nel settore dei prodotti dermatologici a potenziali investitori e professionisti del settore.
Biofrontera Inc. (NASDAQ:BFRI), una empresa biofarmacéutica centrada en la comercialización de productos dermatológicos, ha anunciado su participación en la 3ª Conferencia Anual ROTH sobre Oportunidades en Salud. El evento tendrá lugar en el Metropolitan Club de Nueva York, NY.
Los detalles clave de la presentación de Biofrontera incluyen:
- Fecha: 9 de octubre de 2024
- Hora: 12:30 - 13:10 ET
- Formato: Presentación en vivo
La empresa también ha previsto reuniones uno a uno durante la conferencia. Se aconseja a las partes interesadas que contacten a su representante de Roth para programar estas reuniones.
Esta presentación ofrece a Biofrontera la oportunidad de mostrar sus desarrollos en el sector de productos dermatológicos a posibles inversores y profesionales de la industria.
Biofrontera Inc. (NASDAQ:BFRI), 피부과 제품 상용화에 집중하는 생명공학 회사가 제3회 ROTH 의료 기회 컨퍼런스에 참여한다고 발표했습니다. 이 행사는 뉴욕의 메트로폴리탄 클럽에서 개최됩니다.
Biofrontera의 발표 주요 세부사항은 다음과 같습니다:
- 날짜: 2024년 10월 9일
- 시간: 오후 12:30 - 1:10 ET
- 형식: 라이브 발표
회사는 컨퍼런스 기간 동안 1:1 미팅을 위한 준비도 마쳤습니다. 관심 있는 분들은 이러한 미팅을 위해 Roth 담당자에게 연락하시기 바랍니다.
이번 발표는 Biofrontera가 피부과 제품 분야의 발전을 잠재 투자자 및 산업 전문가에게 선보일 수 있는 기회를 제공합니다.
Biofrontera Inc. (NASDAQ:BFRI), une entreprise biopharmaceutique axée sur la commercialisation de produits dermatologiques, a annoncé sa participation à la 3ème Conférence Annuelle ROTH sur les Opportunités en Santé. L'événement se déroulera au Metropolitan Club à New York, NY.
Les détails clés de la présentation de Biofrontera comprennent :
- Date : 9 octobre 2024
- Heure : 12h30 - 13h10 ET
- Format : Présentation en direct
L'entreprise a également prévu des réunions individuelles pendant la conférence. Les parties intéressées sont invitées à contacter leur représentant Roth pour organiser ces réunions.
Cette présentation offre à Biofrontera l'opportunité de présenter ses développements dans le secteur des produits dermatologiques à de potentiels investisseurs et professionnels de l'industrie.
Biofrontera Inc. (NASDAQ:BFRI), ein biopharmazeutisches Unternehmen, das sich auf die Vermarktung dermatologischer Produkte konzentriert, hat seine Teilnahme an der 3. jährlichen ROTH Healthcare Opportunities Conference angekündigt. Die Veranstaltung findet im Metropolitan Club in New York, NY, statt.
Wichtige Details zur Präsentation von Biofrontera sind:
- Datum: 9. Oktober 2024
- Uhrzeit: 12:30 - 13:10 ET
- Format: Live-Präsentation
Das Unternehmen hat auch Vorkehrungen für persönliche Gespräche während der Konferenz getroffen. Interessierte Parteien werden gebeten, sich an ihren Roth-Vertreter zu wenden, um diese Gespräche zu vereinbaren.
Diese Präsentation bietet Biofrontera die Möglichkeit, seine Entwicklungen im Bereich der dermatologischen Produkte potenziellen Investoren und Branchenfachleuten vorzustellen.
- None.
- None.
WOBURN, MA / ACCESSWIRE / September 25, 2024 / Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatologic products, today announced that management will present at the 3rd Annual ROTH Healthcare Opportunities Conference to be held at the Metropolitan Club in New York, NY.
Date: October 9, 2024
Time of Presentation: 12:30 - 1:10 PM ET
Format: Live Presentation
1x1 Meetings: Please contact your Roth representative
About Biofrontera Inc.
Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company's licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com and follow Biofrontera on LinkedIn and Twitter.
Contacts Investor Relations
Andrew Barwicki
1-516-662-9461
ir@bfri.com
SOURCE: Biofrontera Inc.
View the original press release on accesswire.com
FAQ
When is Biofrontera (BFRI) presenting at the ROTH Healthcare Opportunities Conference?
Where will the 3rd Annual ROTH Healthcare Opportunities Conference be held?
What type of presentation will Biofrontera (BFRI) give at the ROTH conference?
Can investors meet with Biofrontera (BFRI) management at the ROTH conference?
What is Biofrontera's (BFRI) primary business focus?
